封面
市場調查報告書
商品編碼
1620661

藥品品管軟體市場:按功能、部署形式和最終用戶分類 - 2025-2030 年全球預測

Pharmaceutical Quality Management Software Market by Function (Audit Management, Change Management, Corrective Action Preventive Action (CAPA) Management), Deployment Mode (Cloud, On-premise), End-user - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥品品管軟體市值為19.4億美元,預計2024年將達21.8億美元,複合年成長率為12.71%,預計到2030年將達到44.8億美元。

藥品品管軟體 (QMS) 在確保遵守嚴格的監管標準並維持藥品製造和分銷所需的高品質標準方面發揮關鍵作用。該軟體促進整個製藥業務的品質程序自動化、文件管理、偏差追蹤和風險管理。該領域對品質管理系統的需求源於對業務效率、減少錯誤以及遵守 FDA 指南和 GMP 標準等法規的需求。應用範圍包括文件管理、培訓管理、產品設計管理以及糾正措施和預防措施 (CAPA) 管理,為製藥公司、生物技術公司和受託製造廠商(CMO) 等最終用戶提供支援。

主要市場統計
基準年[2023] 19.4億美元
預計年份 [2024] 21.8億美元
預測年份 [2030] 44.8億美元
複合年成長率(%) 12.71%

藥品品質管理系統市場受到對藥品品質標準的日益關注、監管監督的加強和藥品創新的增加的影響。隨著醫療保健產業數位轉型的不斷普及,品質管理系統供應商有機會將先進的分析和人工智慧功能整合到他們的產品中,以增強流程自動化和預測品管。此外,雲端基礎的解決方案的趨勢由於其擴充性和成本效益而顯示出顯著的成長前景。然而,高實施成本、資料隱私問題以及傳統製藥公司抵制變革等挑戰可能會限制市場成長。

對公司而言,創新機會在於增強軟體與現有企業系統的互通性,並開發特定產業的模組來滿足利基製藥需求。投資於使用者友善的介面和行動可訪問性對於提高採用率也至關重要。探索人工智慧驅動的品質預測和虛擬培訓模組,以進一步使您的產品在競爭格局中脫穎而出。隨著市場走向數位化,企業將受益於與科技公司建立策略夥伴關係,並增強其核心能力。為了利用這些機會,公司應該專注於建立靈活且強大的解決方案,以適應不斷變化的法規和市場需求,同時解決部署中的成本和複雜性限制。

市場動態:揭示快速發展的藥品品管軟體市場的關鍵市場洞察

藥品品管軟體市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球藥品製造業持續成長
    • 日益嚴格的法規以維護藥品品質和安全
    • 數位科技在製藥領域的使用增加
  • 市場限制因素
    • 安裝和維護藥品品管軟體的成本高昂
  • 市場機會
    • 擴大引入新的藥品品管軟體
    • 中小藥的新可能
  • 市場挑戰
    • 藥品品管軟體中的隱私和安全問題

波特五力:駕馭藥品品管軟體市場的策略工具

波特的五力架構是了解藥品品管軟體市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解藥品品管軟體市場的外部影響

外部宏觀環境因素在塑造藥品品管軟體市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解藥品品管軟體市場的競爭格局

藥品品管軟體市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥品品管軟體市場供應商的績效評估

FPNV 定位矩陣是評估藥品品管軟體市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製藥品品管軟體市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對藥品品管軟體市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球藥品製造業持續成長
      • 保障藥品品質安全的嚴格監管範圍擴大
      • 數位科技在製藥業的使用增加
    • 抑制因素
      • 安裝和維護藥品品管軟體的成本高昂
    • 機會
      • 新型藥品品管軟體的引進不斷增加
      • 中小藥的新可能
    • 任務
      • 藥品品管軟體中的隱私和安全問題
  • 市場區隔分析
    • 特點:藥品品管軟體在監管和合規管理的使用增加
    • 最終用戶:製藥公司廣泛使用 PQM 軟體來最大限度地降低產品召回的風險。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥品品管軟體市場:依功能

  • 審核管理
  • 變革管理
  • 糾正措施預防措施 (CAPA) 管理
  • 資料管理
  • 檢驗管理
  • 不合格管理
  • 監理與合規管理
  • 風險管理
  • 供應商管理
  • 培訓管理

第7章藥品品管軟體市場:依部署模式

  • 本地

第8章藥品品管軟體市場:依最終用戶分類

  • 生技公司
  • 合約開發製造組織
  • 製藥公司

第9章美洲藥品品管軟體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區藥品品管軟體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲藥品品管軟體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • Aspen Biosciences 推出管道:徹底改變藥物發現管理
    • Recipharm 利用 Veeva Vault Quality Suite 來標準化全球品管業務。
    • Certara 與 Xybion 建立策略聯盟,以改善藥物安全性和有效性的評估
  • 戰略分析和建議

公司名單

  • AmpleLogic
  • Antares Vision SpA
  • Aspen Biosciences
  • AssurX, Inc.
  • Clario
  • ComplianceQuest
  • Dassault Systemes
  • ETQ, LLC by Hexagon AB
  • Ideagen
  • InstantGMP, Inc.
  • IQVIA Inc.
  • Korber Pharma GmbH
  • Marken
  • MasterControl Solutions Inc.
  • Oracle Corporation
  • Qualio, Inc.
  • Qualityze
  • Qualityze Inc.
  • Sarjen Systems Pvt. Ltd
  • Scilife NV
  • SimplerQMS
  • Sparta Systems, Inc. by Honeywell International Inc.
  • Veeva Systems Inc.
  • Xybion
  • Zipbooks Software Solutions Pvt. Ltd.
Product Code: MRR-5C6F41F5B03D

The Pharmaceutical Quality Management Software Market was valued at USD 1.94 billion in 2023, expected to reach USD 2.18 billion in 2024, and is projected to grow at a CAGR of 12.71%, to USD 4.48 billion by 2030.

Pharmaceutical Quality Management Software (QMS) plays a critical role in ensuring compliance with stringent regulatory standards and maintaining the high-quality standards necessary in drug manufacturing and distribution. This software automates quality procedures, manages documentation, tracks deviations, and facilitates risk management across pharmaceutical operations. The necessity of QMS in this sector is driven by the need for operational efficiency, reduction of errors, and compliance with regulations such as FDA guidelines and GMP standards. Its applications span across document control, training management, product design control, and CAPA (Corrective and Preventive Action) management, supporting end-users including pharmaceutical companies, biotechnology firms, and contract manufacturing organizations (CMOs).

KEY MARKET STATISTICS
Base Year [2023] USD 1.94 billion
Estimated Year [2024] USD 2.18 billion
Forecast Year [2030] USD 4.48 billion
CAGR (%) 12.71%

The market for Pharmaceutical QMS is influenced by the rising focus on drug quality standards, increasing regulatory scrutiny, and a growing number of pharmaceutical innovations. The surge in digital transformation initiatives across the healthcare sector has opened opportunities for QMS providers to integrate advanced analytics and AI capabilities into their offerings, enhancing process automation and predictive quality management. Additionally, the trend towards cloud-based solutions presents significant growth prospects due to their scalability and cost-effectiveness. However, challenges such as high implementation costs, data privacy concerns, and resistance to change in traditional pharmaceutical setups may restrict market growth.

For businesses, innovation opportunities lie in enhancing software interoperability with existing enterprise systems and developing industry-specific modules catering to niche pharmaceutical requirements. Investing in user-friendly interfaces and mobile accessibility is also crucial to increase adoption rates. Research into AI-driven quality prediction and virtual training modules can further differentiate offerings in the competitive landscape. As the market leans towards digitalization, companies would benefit by forming strategic partnerships with technology firms to strengthen their core capabilities. To capitalize on these opportunities, organizations should focus on creating flexible and robust solutions that can adapt to evolving regulations and market demands while addressing the limitation of cost and complexity in deployment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Quality Management Software Market

The Pharmaceutical Quality Management Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Continuous increase in manufacturing of drugs globally
    • Growing availability of stringent regulations to maintain quality and safety of drugs
    • Increasing use of digital technologies in the pharmaceutical sector
  • Market Restraints
    • High cost of installation and maintenance of pharmaceutical quality management software
  • Market Opportunities
    • Growing introduction of novel pharmaceutical quality management software
    • Emerging potential in small and mid-size pharmaceutical companies
  • Market Challenges
    • Privacy and security issues with pharmaceutical quality management software

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Quality Management Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Quality Management Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Quality Management Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Quality Management Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Quality Management Software Market

A detailed market share analysis in the Pharmaceutical Quality Management Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Quality Management Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Quality Management Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Quality Management Software Market

A strategic analysis of the Pharmaceutical Quality Management Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Quality Management Software Market, highlighting leading vendors and their innovative profiles. These include AmpleLogic, Antares Vision S.p.A, Aspen Biosciences, AssurX, Inc., Clario, ComplianceQuest, Dassault Systemes, ETQ, LLC by Hexagon AB, Ideagen, InstantGMP, Inc., IQVIA Inc., Korber Pharma GmbH, Marken, MasterControl Solutions Inc., Oracle Corporation, Qualio, Inc., Qualityze, Qualityze Inc., Sarjen Systems Pvt. Ltd, Scilife N.V., SimplerQMS, Sparta Systems, Inc. by Honeywell International Inc., Veeva Systems Inc., Xybion, and Zipbooks Software Solutions Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Quality Management Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Function, market is studied across Audit Management, Change Management, Corrective Action Preventive Action (CAPA) Management, Data Management, Inspection Management, Non-Conformances Management, Regulatory & Compliance Management, Risk Management, Supplier Management, and Training Management.
  • Based on Deployment Mode, market is studied across Cloud and On-premise.
  • Based on End-user, market is studied across Biotechnology Companies, Contract Development and Manufacturing Organizations, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Continuous increase in manufacturing of drugs globally
      • 5.1.1.2. Growing availability of stringent regulations to maintain quality and safety of drugs
      • 5.1.1.3. Increasing use of digital technologies in the pharmaceutical sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of installation and maintenance of pharmaceutical quality management software
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing introduction of novel pharmaceutical quality management software
      • 5.1.3.2. Emerging potential in small and mid-size pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Privacy and security issues with pharmaceutical quality management software
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Function: Increasing use of pharmaceutical quality management software for regulatory & compliance management
    • 5.2.2. End-user: Extensive use PQM software in pharmaceutical companies to minimize the risk of product recalls
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Quality Management Software Market, by Function

  • 6.1. Introduction
  • 6.2. Audit Management
  • 6.3. Change Management
  • 6.4. Corrective Action Preventive Action (CAPA) Management
  • 6.5. Data Management
  • 6.6. Inspection Management
  • 6.7. Non-Conformances Management
  • 6.8. Regulatory & Compliance Management
  • 6.9. Risk Management
  • 6.10. Supplier Management
  • 6.11. Training Management

7. Pharmaceutical Quality Management Software Market, by Deployment Mode

  • 7.1. Introduction
  • 7.2. Cloud
  • 7.3. On-premise

8. Pharmaceutical Quality Management Software Market, by End-user

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Contract Development and Manufacturing Organizations
  • 8.4. Pharmaceutical Companies

9. Americas Pharmaceutical Quality Management Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Quality Management Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Quality Management Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Aspen Biosciences Launches Pipeline: Revolutionizing Drug Discovery Management
    • 12.3.2. Recipharm Leverages Veeva Vault Quality Suite to Standardize Global Quality Management Operations"
    • 12.3.3. Strategic Collaboration between Certara and Xybion to Improve Drug Safety and Efficacy Evaluation
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AmpleLogic
  • 2. Antares Vision S.p.A
  • 3. Aspen Biosciences
  • 4. AssurX, Inc.
  • 5. Clario
  • 6. ComplianceQuest
  • 7. Dassault Systemes
  • 8. ETQ, LLC by Hexagon AB
  • 9. Ideagen
  • 10. InstantGMP, Inc.
  • 11. IQVIA Inc.
  • 12. Korber Pharma GmbH
  • 13. Marken
  • 14. MasterControl Solutions Inc.
  • 15. Oracle Corporation
  • 16. Qualio, Inc.
  • 17. Qualityze
  • 18. Qualityze Inc.
  • 19. Sarjen Systems Pvt. Ltd
  • 20. Scilife N.V.
  • 21. SimplerQMS
  • 22. Sparta Systems, Inc. by Honeywell International Inc.
  • 23. Veeva Systems Inc.
  • 24. Xybion
  • 25. Zipbooks Software Solutions Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY AUDIT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CHANGE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CORRECTIVE ACTION PREVENTIVE ACTION (CAPA) MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY INSPECTION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY NON-CONFORMANCES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY REGULATORY & COMPLIANCE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY SUPPLIER MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY TRAINING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023